Literature DB >> 28555082

Identification of a novel PML-RARG fusion in acute promyelocytic leukemia.

J-S Ha1, Y R Do2, C-S Ki3, C Lee4,5, D-H Kim1, W Lee1, N-H Ryoo1, D-S Jeon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28555082     DOI： 10.1038/leu.2017.167

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia.

Authors:  A Marinelli; D Bossi; P G Pelicci; S Minucci
Journal:  Leukemia       Date:  2007-01-25       Impact factor: 11.528

2.  Redundant function of retinoic acid receptor isoforms in leukemogenesis unravels a prominent function of genome topology and architecture in the selection of mutagenic events in cancer.

Authors:  A Marinelli; D Bossi; P G Pelicci; S Minucci
Journal:  Leukemia       Date:  2008-08-07       Impact factor: 11.528

3.  In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene.

Authors:  Esperanza Such; Lourdes Cordón; Amparo Sempere; Eva Villamón; Mariam Ibañez; Irene Luna; Inés Gómez-Seguí; María López-Pavía; Carmen Alonso; Francesco Lo-Coco; Jose Cervera; Miguel A Sanz
Journal:  Ann Hematol       Date:  2014-04-13       Impact factor: 3.673

4.  A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.

Authors:  Esperanza Such; José Cervera; Ana Valencia; Eva Barragán; Mariam Ibañez; Irene Luna; Oscar Fuster; Maria Luz Perez-Sirvent; Leonor Senent; Amparo Sempere; Jesús Martinez; Guillermo Martín-Aragonés; Miguel A Sanz
Journal:  Blood       Date:  2010-10-08       Impact factor: 22.113

Review 5.  A decade of molecular biology of retinoic acid receptors.

Authors:  P Chambon
Journal:  FASEB J       Date:  1996-07       Impact factor: 5.191

6.  Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.

Authors:  J J Qiu; B B Zeisig; S Li; W Liu; H Chu; Y Song; A Giordano; J Schwaller; H Gronemeyer; S Dong; C W E So
Journal:  Leukemia       Date:  2014-12-16       Impact factor: 11.528

7.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications.

Authors:  Xiaoyu Chen; Ole Schulz-Trieglaff; Richard Shaw; Bret Barnes; Felix Schlesinger; Morten Källberg; Anthony J Cox; Semyon Kruglyak; Christopher T Saunders
Journal:  Bioinformatics       Date:  2015-12-08       Impact factor: 6.937

8.  BreakDancer: an algorithm for high-resolution mapping of genomic structural variation.

Authors:  Ken Chen; John W Wallis; Michael D McLellan; David E Larson; Joelle M Kalicki; Craig S Pohl; Sean D McGrath; Michael C Wendl; Qunyuan Zhang; Devin P Locke; Xiaoqi Shi; Robert S Fulton; Timothy J Ley; Richard K Wilson; Li Ding; Elaine R Mardis
Journal:  Nat Methods       Date:  2009-08-09       Impact factor: 28.547
  8 in total
  12 in total

1.  A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion.

Authors:  Christopher A Miller; Christopher Tricarico; Zachary L Skidmore; Geoffrey L Uy; Yi-Shan Lee; Anjum Hassan; Michelle D O'Laughlin; Heather Schmidt; Ling Tian; Eric J Duncavage; Malachi Griffith; Obi L Griffith; John S Welch; Lukas D Wartman
Journal:  Blood Adv       Date:  2018-06-12

2.  Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions.

Authors:  Lijun Wen; Yang Xu; Li Yao; Nana Wang; Qinrong Wang; Tianhui Liu; Jinlan Pan; Jiannong Cen; Huifeng Zhou; Miao Miao; Yang W Shao; Xiaonan Wang; Xiaoxia Wang; Changgeng Ruan; Depei Wu; Suning Chen
Journal:  Haematologica       Date:  2018-09-20       Impact factor: 9.941

3.  Novel reciprocal fusion genes involving HNRNPC and RARG in acute promyelocytic leukemia lacking RARA rearrangement.

Authors:  Zhan Su; Xin Liu; Yan Xu; Weiyu Hu; Chunting Zhao; Hongguo Zhao; Xianqi Feng; Shuchao Zhang; Jie Yang; Xue Shi; Jun Peng
Journal:  Haematologica       Date:  2020-04-30       Impact factor: 9.941

Review 4.  Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Authors:  Xiang Zhang; Jiewen Sun; Wenjuan Yu; Jie Jin
Journal:  Biomark Res       Date:  2021-05-06

5.  A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide.

Authors:  Xue Chen; Fang Wang; Yang Zhang; Wen Teng; Panxiang Cao; Xiaoli Ma; Mingyue Liu; Yaoyao Tian; Tong Wang; Daijing Nie; Jing Zhang; Hongxing Liu; Wei Wang
Journal:  Br J Cancer       Date:  2019-04-18       Impact factor: 7.640

Review 6.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

Review 7.  RARG Gene Dysregulation in Acute Myeloid Leukemia.

Authors:  Maria Rosa Conserva; Immacolata Redavid; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Front Mol Biosci       Date:  2019-10-24

Review 8.  Classic and Variants APLs, as Viewed from a Therapy Response.

Authors:  Marie-Claude Geoffroy; Hugues de Thé
Journal:  Cancers (Basel)       Date:  2020-04-14       Impact factor: 6.639

Review 9.  Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene.

Authors:  Alessandro Liquori; Mariam Ibañez; Claudia Sargas; Miguel Ángel Sanz; Eva Barragán; José Cervera
Journal:  Cancers (Basel)       Date:  2020-03-08       Impact factor: 6.639

10.  Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report.

Authors:  Wei Wei; Qiuju Liu; Fei Song; He Cao; Mengmeng Liu; Yan Jiang; Yanchun Li; Sujun Gao
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.